Phospho-NFATC4 (S168/S170) Antibody

What is the biological significance of NFATC4 phosphorylation at Serine 168/170?

The phosphorylation state of NFATC4 at Ser168/170 is crucial for regulating its subcellular localization and transcriptional activity. Research indicates that the activation of NFATC4 requires dephosphorylation at these specific serine residues (Ser168 and Ser170), which triggers its translocation from the cytoplasm to the nucleus . When phosphorylated at these sites, NFATC4 predominantly remains in the cytoplasm, preventing its transcriptional functions. Conversely, dephosphorylation by calcineurin (a calcium-dependent phosphatase) enables nuclear translocation, allowing NFATC4 to regulate target gene expression . This phosphorylation-dependent shuttling mechanism represents a critical checkpoint in NFATC4-mediated signaling pathways associated with cardiac development, inflammatory responses, and fibrotic disease progression .

How does NFATC4 phosphorylation state relate to its function in different tissue contexts?

NFATC4 phosphorylation status differentially affects its function across various tissues. In cardiac tissue, dephosphorylated NFATC4 translocates to the nucleus and participates in pathways related to cardiac hypertrophy and remodeling . In fibroblasts, changes in NFATC4 phosphorylation at specific serine residues respond to tissue stiffness, with phosphorylation at S213/S217 enhancing myofibroblast activity - a key hallmark of fibrotic diseases . NFATC4 is widely expressed, with particularly high levels reported in placenta, lung, kidney, testis, and ovary . In each of these contexts, the phosphorylation state serves as a molecular switch controlling NFATC4's ability to regulate tissue-specific gene expression programs related to development, inflammatory responses, or pathological conditions.

What are the key considerations when selecting a Phospho-NFATC4 (S168/S170) Antibody for research applications?

When selecting a Phospho-NFATC4 (S168/S170) Antibody, researchers should consider several critical factors:

Most commercially available Phospho-NFATC4 (S168/S170) antibodies are produced in rabbits and demonstrate reactivity with human and mouse samples . These antibodies typically perform well in Western blotting, immunohistochemistry, and immunocytochemistry applications .

What controls should be included when using Phospho-NFATC4 (S168/S170) Antibody in experimental protocols?

A robust experimental design using Phospho-NFATC4 (S168/S170) Antibody should incorporate the following controls:

• Phosphatase treatment control: Treating a portion of your sample with lambda phosphatase will dephosphorylate the target sites, providing a negative control for phospho-specific antibody binding.

• Phosphorylation-inducing treatment: Samples treated with agents known to induce NFATC4 phosphorylation (such as phenylephrine in cardiomyocytes) serve as positive controls .

• Total NFATC4 antibody: Parallel detection with an antibody recognizing total NFATC4 regardless of phosphorylation state allows normalization of phosphorylation levels.

• Subcellular fractionation validation: When studying nuclear translocation, include markers specific to nuclear (LaminB1) and cytoplasmic (α-tubulin) fractions to verify fractionation quality .

• NFATC4 knockdown/knockout: Samples with reduced or eliminated NFATC4 expression validate antibody specificity.

• Peptide competition: Pre-incubating the antibody with the phosphorylated peptide immunogen should block specific binding.

These controls are essential for distinguishing genuine phospho-NFATC4 signal from potential artifacts or non-specific binding.

What are the most effective methods for detecting changes in NFATC4 phosphorylation at S168/S170 in response to experimental stimuli?

Several complementary techniques can effectively detect changes in NFATC4 phosphorylation:

• Western Blotting with Subcellular Fractionation:

  • Separate nuclear and cytoplasmic fractions before immunoblotting

  • Probe with Phospho-NFATC4 (S168/S170) antibody

  • Normalize to total NFATC4 and fraction-specific markers (LaminB1 for nuclear, α-tubulin for cytoplasmic)

  • This approach allows quantification of both phosphorylation state and subcellular localization

• Immunofluorescence Microscopy:

  • Fix cells using paraformaldehyde (typically 4%)

  • Perform dual staining with Phospho-NFATC4 (S168/S170) antibody and total NFATC4 antibody

  • Counterstain nuclei with DAPI

  • This method provides visual confirmation of NFATC4 nuclear translocation upon dephosphorylation

• Co-Immunoprecipitation:

  • Immunoprecipitate with total NFATC4 antibody

  • Probe immunoprecipitates with Phospho-NFATC4 (S168/S170) antibody

  • This approach can reveal dynamic interactions with regulatory proteins based on phosphorylation state

• Phosphoproteomics:

  • Employ mass spectrometry-based approaches for unbiased detection

  • This technique can identify multiple phosphorylation sites simultaneously and quantify their relative abundance

The choice of method depends on the specific research question, with combining multiple approaches providing the most comprehensive analysis.

How should samples be prepared to preserve NFATC4 phosphorylation status for accurate antibody detection?

Preserving phosphorylation status is critical for accurate results when working with phospho-specific antibodies:

• Sample Collection and Lysis:

  • Include phosphatase inhibitors (sodium fluoride, sodium pyrophosphate, sodium orthovanadate) in all buffers

  • Maintain cold temperatures throughout sample processing

  • Use lysis buffers containing 1% NP-40 or Triton X-100, 150mM NaCl, 50mM Tris-HCl (pH 7.4)

  • Process samples rapidly to minimize dephosphorylation

• Subcellular Fractionation:

  • For nuclear/cytoplasmic separation, use specialized kits or established protocols with phosphatase inhibitors

  • Verify fraction purity by probing for compartment-specific markers

• Tissue Samples:

  • Flash-freeze tissues immediately in liquid nitrogen

  • Consider preservation methods like heat stabilization when applicable

  • For FFPE samples, optimize antigen retrieval conditions for phospho-epitopes

• Fixation for Immunostaining:

  • Use 4% paraformaldehyde fixation for 10-15 minutes at room temperature

  • Avoid methanol fixation which can extract phospholipids and affect epitope recognition

  • Include phosphatase inhibitors in wash buffers

Precise attention to these preparation details significantly improves detection of the genuine phosphorylation state at the time of sample collection.

How can researchers differentiate between changes in NFATC4 phosphorylation versus changes in total NFATC4 expression?

Distinguishing phosphorylation changes from expression changes requires a careful experimental approach:

• Parallel Detection Strategy:

  • Always probe for both phosphorylated NFATC4 (S168/S170) and total NFATC4

  • Calculate the phospho-NFATC4/total NFATC4 ratio to normalize for expression differences

  • Include housekeeping protein controls (GAPDH, β-actin) for loading normalization

• Time-Course Analysis:

  • Phosphorylation changes typically occur more rapidly (minutes to hours) than expression changes (hours to days)

  • Performing time-course experiments can help differentiate these events

• Protein Synthesis Inhibition:

  • Using cycloheximide to block new protein synthesis can help isolate post-translational modifications from expression changes

  • This approach confirms whether observed changes are due to altered phosphorylation of existing protein

• Phosphatase/Kinase Manipulation:

  • Specific inhibition or activation of relevant phosphatases (calcineurin) or kinases (p38 MAPK) can directly demonstrate phosphorylation-specific effects

  • Compare these results with transcriptional/translational inhibitors

By implementing these strategies, researchers can confidently attribute observed changes to either phosphorylation dynamics or altered protein expression.

What are the key technical challenges in detecting NFATC4 phosphorylation at S168/S170, and how can they be addressed?

Detection of NFATC4 phosphorylation presents several technical challenges:

Additionally, researchers should be aware of potential nomenclature inconsistencies in the literature regarding phosphorylation sites. Some reports refer to S168/S170, while others may use different numbering systems (e.g., S213/S217) , potentially reflecting species differences or alternative splicing variants.

How can researchers investigate the interplay between NFATC4 phosphorylation, acetylation, and other post-translational modifications?

The complex regulation of NFATC4 involves multiple interacting post-translational modifications:

• Sequential Immunoprecipitation Approach:

  • First immunoprecipitate with anti-NFATC4 antibody

  • Divide the precipitate and probe separately for phosphorylation and acetylation

  • This approach reveals the relative abundance of differently modified pools

• Mass Spectrometry-Based Analysis:

  • Employ enrichment techniques for both phosphorylated and acetylated peptides

  • Analyze using high-resolution mass spectrometry

  • This allows comprehensive mapping of multiple modification sites

• Investigating Modification Crosstalk:

  • Apply specific deacetylase inhibitors (for SIRT6) and examine effects on phosphorylation status

  • Similarly, manipulate phosphorylation status and assess impacts on acetylation

  • Research indicates SIRT6 interacts with and deacetylates NFATC4, potentially affecting its phosphorylation state

• Proximity Ligation Assays:

  • Use antibodies against differently modified forms of NFATC4

  • This technique visualizes physical proximity of distinct modifications on individual protein molecules

These approaches help unravel how different modifications collectively regulate NFATC4 function, particularly the interplay between SIRT6-mediated deacetylation and phosphorylation at S168/S170 that affects nuclear export and transcriptional activity .

What experimental approaches can elucidate the relationship between mechanical signals and NFATC4 phosphorylation in the context of fibrotic diseases?

Investigating mechanosensing effects on NFATC4 phosphorylation requires specialized approaches:

• Tunable Substrate Stiffness Systems:

  • Culture cells on hydrogels with defined elastic moduli (1-100 kPa)

  • Analyze NFATC4 phosphorylation states across stiffness gradients

  • This mimics the mechanical environment of healthy versus fibrotic tissues

• Stretching and Compression Devices:

  • Apply controlled mechanical forces to cell cultures

  • Monitor acute changes in NFATC4 phosphorylation

  • Correlate with activation of mechanosensitive pathways

• 3D Culture Systems:

  • Establish cells in 3D matrices with variable stiffness

  • Analyze nuclear deformation in relation to NFATC4 phosphorylation and localization

  • This better recapitulates the in vivo microenvironment

• Targeted Manipulation of Mechanosensing Components:

  • Disrupt specific mechanosensors (integrins, cytoskeletal components)

  • Assess consequent changes in NFATC4 phosphorylation

  • This identifies upstream regulators in the mechanotransduction pathway

• Phosphoproteomic Analysis:

  • Compare phosphorylation profiles between normal and stiff environments

  • Identify mechanically regulated kinases and phosphatases affecting NFATC4

  • Research shows stiffness-dependent phosphorylation affects NFATC4 function in myofibroblast activity

These approaches help establish causal links between mechanical cues, NFATC4 phosphorylation status, and downstream fibrotic processes, potentially identifying intervention points for anti-fibrotic therapies.

What are common artifacts or false results when working with Phospho-NFATC4 (S168/S170) Antibody, and how can they be identified?

Researchers should be vigilant about several potential artifacts:

• Non-specific Bands in Western Blots:

  • NFATC4 exists as multiple isoforms with different molecular weights (ranging from 90-190 kDa)

  • Solution: Include positive controls with known NFATC4 expression; perform peptide competition assays

• False Cytoplasmic vs. Nuclear Distribution:

  • Improper fractionation or fixation can misrepresent true localization

  • Solution: Validate fractionation quality with established markers (LaminB1, α-tubulin)

• Phosphatase Activity During Sample Preparation:

  • Even brief phosphatase activity can significantly alter results

  • Solution: Strict adherence to phosphatase inhibitor protocols; immediate denaturation when possible

• Antibody Cross-reactivity:

  • Some antibodies might recognize multiple NFAT family members

  • Solution: Validate specificity with NFATC4 knockdown/knockout samples

• Fixation-Induced Epitope Masking:

  • Overfixation can mask phospho-epitopes

  • Solution: Optimize fixation conditions; consider alternative antigen retrieval methods

• NFATC4 Site Numbering Confusion:

  • Literature discrepancies in phosphorylation site numbering (S168/S170 vs. S213/S217)

  • Solution: Cross-reference antibody immunogen sequence with protein database entries

Careful experimental design with appropriate controls and awareness of these potential issues significantly improves data reliability.

How can researchers optimize immunoprecipitation protocols specifically for studying phosphorylated NFATC4?

Optimizing immunoprecipitation (IP) for phosphorylated NFATC4 requires special considerations:

• Antibody Selection Strategy:

  • For detecting specific phospho-forms: Immunoprecipitate with total NFATC4 antibody, then probe with phospho-specific antibody

  • For enriching phosphorylated forms: Immunoprecipitate directly with Phospho-NFATC4 antibody

  • Current literature suggests the former approach yields more reliable results

• Buffer Optimization:

  • Include phosphatase inhibitors (50mM NaF, 1mM Na3VO4, 10mM β-glycerophosphate)

  • Use mild detergents (0.5-1% NP-40) to preserve protein-protein interactions

  • Maintain physiological pH (7.2-7.4) and moderate salt concentration (150mM NaCl)

• Handling Protein Complexes:

  • Consider crosslinking approaches for transient interactions

  • When studying NFATC4-calcineurin interactions, calcium concentration in buffers is critical

  • Research shows relevant interactions between NFATC4, SIRT6, and p38 MAPK

• Technical Enhancements:

  • Pre-clear lysates with protein A/G beads to reduce background

  • Use magnetic beads for gentler handling and better recovery

  • Consider sequential IPs to isolate specific sub-complexes

• Validation Approaches:

  • Perform reverse IPs (immunoprecipitate interacting protein, detect NFATC4)

  • Include IgG control immunoprecipitations

  • Validate with overexpression and knockdown controls

These optimizations significantly improve detection of physiologically relevant NFATC4 phosphorylation and associated protein interactions that regulate its function.